October 2019
In this Issue
Interventional Oncology
Practical Tips and Insights On The Future of Image-Guided Cancer Therapies.
Issue
Supplement
Guest Chief Medical Editors’ Page
Enhancing Interventional Oncology
By Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
COVER STORIES
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Year in Review: Top Papers in Interventional Oncology
Eric Wehrenberg-Klee, MD, and Suvranu “Shoey” Ganguli, MD, FSIR, provide an overview of the most significant interventional oncology articles published in the recent literature, with summaries on the impact that each has had on the field.
By Eric Wehrenberg-Klee, MD; and Suvranu “Shoey” Ganguli, MD, FSIR
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Outpatient Interventional Oncology: Primum Non Nocere
Top tips for treating patients and avoiding complications in the outpatient setting.
By Edgar D. St. Amour, MD; David Hays, MD; and Ripal T. Gandhi, MD, FSIR, FSVM
Immunotherapy and Checkpoint Inhibitors: A Primer for the Interventional Radiologist
The basics of immunology, immunotherapy, and checkpoint inhibitors.
By Joseph P. Erinjeri, MD, PhD; and Daniel T. Sze, MD, PhD
Update on Treatment of Cancer-Associated Thrombosis
Current recommendations, results of recently completed trials on anticoagulation therapy, and applications of endovascular interventions.
By Nicholas Fidelman, MD
ONLINE EXCLUSIVE
Mentors and Protégés: Conversations on Career and Craft With Robert J. Lewandowski, MD, FSIR
Adam Sucher, DO, talks with Dr. Lewandowski about his work in early interventional oncology and IVC filters, how to meld clinical and research interests, balancing competing priorities, and more.
FEATURED TECHNOLOGY
Sponsored by Inari Medical
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
MEDICAL AFFAIRS CORNER
Sponsored by MedtronicIntraprocedural Monitoring of Blood Flow Using FlowMet-R
By Mahmood K. Razavi, MD, FSIR, FSVM
DEPARTMENTS
An Interview With Akhilesh K. Sista, MD, FSIR, FAHA
Dr. Sista discusses the PE-TRACT trial’s origin, goals, and current status, as well as what it’s like to run a PERT in New York City.
advertisement
Top 5 Articles From October 2019
What’s New in Y-90?
Technical and procedural innovations in Y-90 radioembolization including existing and investigational next-generation technologies.
By Robert Abraham, MD, FRCPC, FSIR; Robert Lewandowski, MD, FSIR; Ripal T. Gandhi, MD, FSIR, FSVM; and David M. Liu, MD, FRCPC, FSIR
Transradial Access for Hepatic Oncologic Interventions
Considerations for choosing the right access equipment.
By Darren Klass, MBChB, MD, MRCS, FCRC, FRCPC; Anastasia Hadjivassiliou, MBBS, FRCR, FRCPC; and John Chung, MD, FRCPC
Is It Time to End the Therapeutic Nihilism Toward Treating VTE in Cancer Patients?
Cases highlighting the potential for early benefit and improved quality of life and function associated with the use of FlowTriever and ClotTriever Systems in patients with cancer and VTE.
With Sirish A. Kishore, MD; and William C. Dillon, MD, FACC
Contemporary Management of Pancreatic Cancer
An update on state-of-the-art minimally invasive therapies, including recent advances in surgery, radiation therapy, ablative options, and endovascular therapies.
By Ripal T. Gandhi, MD, FSIR, FSVM; Horacio Asbun, MD; Michael Chuong, MD; Filipe Kunzler, MD; and Govindarajan Narayanan, MD
Top Tips in Interventional Oncology
Clinical and technical insights into treating hepatocellular carcinoma, cholangiocarcinoma, renal cell carcinoma, lung cancer, bone cancer, and in the palliative care setting.
By Siddharth A. Padia, MD; Theodore Bryan, MD; Rebecca Bennett, MD; Nadine Abi-Jaoudeh, MD, FSIR, CCRP; Raul N. Uppot, MD; Robert Suh, MD; Paul I. Mallinson, MBChB, FRCR, FRCPC; Peter L. Munk, MDCM, FRCPC, FSIR, FFRRCSI (Hon); Miyuki Sone, MD; and Yasuaki Arai, MD, FSIR, FCIRSE
Top 5 from CIToday's Current Issue
Massive Thromboembolism, PFO, and Acute Limb Ischemia
By Moderator: Mohamad Alkhouli, MD
Panelists: Yashu Dhamija, MD; Abdul Moiz Hafiz, MD; Ankur Kalra, MD, FACP, FACC, FSCAI; and Anmar Kanaa’N, MD
Meeting the Challenge…
By Azeem Latib, MD
Compensation and Production Trends for Interventionalists
A look at MedAxiom’s annual report reflecting the continued evolution of the field in terms of physician demand and compensation agreements.
